Alexion Pharmaceuticals - Company & Market Research Reports

Home /
Companies /
Alexion Pharmaceuticals

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 63
Central Nervous System Drugs 54
Immune Disorders Drugs 31
Biopharmaceuticals 27
Hematological Drugs 25
Cardiovascular Drugs 24
Endocrine and Metabolic Disorders Drugs 24
Pharmaceuticals 22
Biotechnology 20
Clinical Trials 18
Liver and Kidney Disorders Drugs 17
Oncology Drugs 14
Allergy and Immunology 13
Genomics 12
Musculoskeletal Disorders Drugs 12
Enzymes 11
Optical Disorders Drugs 8
Infusions and Injectables 8
Company Reports 7
Drugs by Therapeutic Area 7
Drug Delivery 6
Hematology 6
Therapeutic Area 5
Needles and Syringes 5
Dermatological Drugs 5
Infectious Diseases Drugs 4
In Vitro Diagnostics 4
Medical Devices 4
Vaccines 4
Respiratory Drugs 4
Biosimilars and Biosuperiors 4
Proteomics 3
Diagnostics 3
Gastrointestinal Drugs 3
Laboratory Equipment 3
Allergy Drugs 3
Pharmaceutical Manufacturing 3
Pharmaceutical Intermediates 2
Leukemia Drugs 2
Lymphoma Drugs 2
Optical 2
Blood Banking 2
Immunosuppressive Drugs 2
Addiction Disorders Drugs 1
Urology and Nephrology 1
Healthcare Services 1
Pharmacoeconomics 1
Women's Health 1
Colon Cancer Drugs 1
Bioinformatics 1
Cardiovascular Devices 1
Stents 1
Infectious Disease Testing 1
Analgesics 1
Cough and Cold Drugs 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Nanomedicine 1
Gastroenterology 1
Oncology 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

364 Results (Page 4 of 19)
- Relevance
  Sort by

Rare Kidney Diseases Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4835EUR$5,000USD£4,095GBP

Peptide Therapeutics Market by Type of Peptide, Route of Administration, Key Geographical Regions and Key Therapeutic Area: Industry Trends and Global Forecasts, 2021 - 2030

 Report
April 2021
250 Pages
Global

From

€4641EUR$4,799USD£3,930GBP

Global Myasthenia Gravis Treatment Market by Type (Medication, Surgery), End-User (Clinics, Hospitals) - Forecast 2024-2030

 Report
March 2024
199 Pages
Global

From

€3263EUR$3,374USD£2,763GBP

€3625EUR$3,749USD£3,070GBP

Myasthenia Gravis Drugs - Global Strategic Business Report

 Report
April 2024
182 Pages
Global

From

€4787EUR$4,950USD£4,054GBP

Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review

 Report
April 2024
Global

From

€300EUR$332USD£263GBP

NEED HELP FINDING THE RIGHT PRODUCT? Dale will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028

 Report
July 2022
2190 Pages
Global

From

€3481EUR$3,600USD£2,948GBP

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

 Report
July 2023
3600 Pages
United States

From

€8703EUR$9,000USD£7,371GBP

Synthetic Biology Market Report 2022-2032

 Report
July 2022
745 Pages
Global

From

€4827EUR$5,167USD£3,950GBP

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Diagnostic Test (Bone Marrow Examination, Complete Blood Count Test, Flow Cytometry), Treatment (Blood Transfusion, Medication, Stem Cell Transplant) - Forecast 2024-2030

 Report
March 2024
189 Pages
Global

From

€3263EUR$3,374USD£2,763GBP

€3625EUR$3,749USD£3,070GBP

Collaboration Deals in Biotechnology 2019-2024

 Report
March 2024
1100 Pages
Global

From

€3863EUR$3,995USD£3,272GBP

Licensing Deals in Biotechnology 2019-2024

 Report
March 2024
1100 Pages
Global

From

€3863EUR$3,995USD£3,272GBP

Global Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

 Report
June 2023
204 Pages
Global

From

€3481EUR$3,600USD£2,948GBP

Global Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Forecast 2024-2030

 Report
March 2024
181 Pages
Global

From

€3263EUR$3,374USD£2,763GBP

€3625EUR$3,749USD£3,070GBP

Biopharmaceuticals - A Global Market Overview

 Report
May 2019
480 Pages
Global

From

€4352EUR$4,500USD£3,685GBP

Pre-Eclampsia - Global Clinical Trials Review, H2, 2021

 Clinical Trials
July 2021
256 Pages
Global

From

€2418EUR$2,500USD£2,047GBP

Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026

 Report
October 2021
210 Pages
Global

From

€3626EUR$3,750USD£3,071GBP

Biopharmaceutical CMO Global Market Report 2024

 Report
December 2023
200 Pages
Global

From

€4835EUR$5,000USD£4,095GBP

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) (Gastrointestinal) - Drugs in Development, 2021

 Drug Pipelines
March 2021
Global

From

€1934EUR$2,000USD£1,638GBP

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4835EUR$5,000USD£4,095GBP

Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Enzyme Type, Therapeutic Conditions, Route of Administration, and End User

 Report
July 2022
226 Pages
Global

From

€3080EUR$3,185USD£2,608GBP

€4400EUR$4,550USD£3,726GBP

364 Results (Page 4 of 19)
- 1
- 2
- 3
- 4
- 5
- 6

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.